Arrowhead Pharmaceuticals

$62.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.56 (-2.45%) Today
-$0.02 (-0.03%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ARWR and other stocks, options, and ETFs commission-free!

About ARWR

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them.

CEO
Christopher Richard Anzalone
Employees
232
Headquarters
Pasadena, California
Founded
1989
Market Cap
6.60B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
632.19K
High Today
$63.20
Low Today
$61.31
Open Price
$63.20
Volume
783.18K
52 Week High
$92.60
52 Week Low
$30.83

ARWR Earnings

-$0.48
-$0.26
-$0.05
$0.17
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

IMAB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure